Total submissions: 24
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000176065 | SCV000152677 | likely benign | not specified | 2014-09-10 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000176065 | SCV000227659 | likely benign | not specified | 2014-11-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080021 | SCV000299165 | benign | Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000176065 | SCV000309315 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000383539 | SCV000418425 | benign | Paroxysmal extreme pain disorder | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000714847 | SCV000418427 | benign | Primary erythromelalgia | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000389147 | SCV000418428 | likely benign | Inherited Erythromelalgia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000335798 | SCV000418430 | likely benign | Channelopathy-associated congenital insensitivity to pain, autosomal recessive | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000422016 | SCV000511746 | likely benign | not provided | 2016-11-07 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000422016 | SCV000514589 | benign | not provided | 2020-05-13 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28440294, 29934995, 23895530, 29911575, 29264398, 32707200) |
Ce |
RCV000422016 | SCV000575255 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | SCN9A: BS2 |
ARUP Laboratories, |
RCV000422016 | SCV000605066 | benign | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000422016 | SCV000843750 | benign | not provided | 2018-06-21 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000328939 | SCV000845584 | uncertain significance | Severe myoclonic epilepsy in infancy | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000714847 | SCV000845585 | uncertain significance | Primary erythromelalgia | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000714848 | SCV000845586 | uncertain significance | Neuropathy, hereditary sensory and autonomic, type 2A | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000768312 | SCV000898959 | uncertain significance | Primary erythromelalgia; Paroxysmal extreme pain disorder; Severe myoclonic epilepsy in infancy; Channelopathy-associated congenital insensitivity to pain, autosomal recessive; Generalized epilepsy with febrile seizures plus, type 7 | 2018-10-22 | criteria provided, single submitter | clinical testing | SCN9A NM_002977.3 exon 20 p.Asn1245Ser (c.3734A>G): This variant has been reported in the literature in 2 individuals with erythromelalgia (Zhang 2014 PMID:29911575, Haehner 2018 PMID:29934995). This variant was also seen in one individual with language impairment who also carried a second variant in SCN9A (Chen 2017 PMID:28440294). This variant is present in 0.7% (933/126946) of European alleles, including 2 homozygotes, in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/2-167094638-T-C). This variant is present in ClinVar, with several labs classifying this variant as likely benign (Variation ID:130265). However, evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Mendelics | RCV000714848 | SCV001136078 | likely benign | Neuropathy, hereditary sensory and autonomic, type 2A | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345422 | SCV002621197 | likely benign | Inborn genetic diseases | 2019-09-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomics, |
RCV003224155 | SCV003920460 | uncertain significance | Primary erythromelalgia; Paroxysmal extreme pain disorder; Channelopathy-associated congenital insensitivity to pain, autosomal recessive | 2021-03-30 | criteria provided, single submitter | clinical testing | SCN9A NM_002977.3 exon 20 p.Asn1245Ser (c.3734A>G): This variant has been reported in the literature in 2 individuals with erythromelalgia (Zhang 2014 PMID:29911575, Haehner 2018 PMID:29934995). This variant was also seen in one individual with language impairment who also carried a second variant in SCN9A (Chen 2017 PMID:28440294). This variant is present in 0.7% (933/126946) of European alleles, including 2 homozygotes, in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/2-167094638-T-C). This variant is present in ClinVar, with several labs classifying this variant as likely benign (Variation ID:130265). However, evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Clinical Genetics, |
RCV000176065 | SCV001922999 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000422016 | SCV001928611 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000422016 | SCV001953444 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000422016 | SCV001964676 | likely benign | not provided | no assertion criteria provided | clinical testing |